The world is witnessing a rapidly rising incidence of Gastrointestinal (GI) disorders like IBS (Irritable Bowel Syndrome), GERD (Gastroesophageal Reflux Disease), Inguinal Hernia, Celiac Disease, Diarrhea, and Constipation, among others. These diseases are chronic & highly prevalent and bring significant impairments in quality of life. As a result, there's a mounting need for new GI therapeutics like Minimally Invasive Surgeries (MIS), particularly laparoscopy & robotic surgeries, which involve small incisions, more precision & safety, faster recovery, & less pain in order to cater to the high unmet needs of patients with such ailments.
The Global Minimally Invasive Gastrointestinal Surgical Systems Market is projected to grow at around 7% CAGR during 2022-27. Most of the market expansion would be driven by the mounting incidence & recurrence of GI diseases worldwide, such as colorectal cancer, GERD, hernia, and inflammatory bowel syndrome (IBS), i.e., due to unhealthy eating habits & changing lifestyles of people. Besides, the rising elderly population globally, which is most prone to these illnesses, is also significantly contributing to the market growth.
Moreover, rising intricacies in clinical decision-making, the immense burden on radiologists, massive investments in R&D & healthcare infrastructure development, and the growing number of promising results in minimally invasive surgeries are further boosting the market.
|Study Period||Historical Data: 2017-20|
|Base Year: 2021|
|Forecast Period: 2022-27|
|Regions Covered||North America: The US, Canada|
|Europe: Germany, The UK, France, Italy, Spain, Rest of Europe|
|Asia-Pacific: China, Japan, India, South Korea, Australia, Rest of Asia Pacific|
|Rest of the World|
|Key Companies Profiled||B. Braun Melsungen AG, Conmed Corporation, Karl Storz SE & Co. KG, Medtronic plc, Olympus Corporation, Stryker Corporation, TransEnterix, Inc, Boston Scientific Corporation, Cook Medical, Inc, Richard Wolf GmbH, Intuitive Surgical, Inc, Ambu A/S, Schölly Fiber Optic GmbH, Xenocor, Inc, Fujifilm Holdings Corporation, Pentax Medical (Hoya Corporation)|
|Unit Denominations||USD Million/Billion|
Minimally invasive gastrointestinal surgeries are as effective as conventional surgical systems, and, in fact, they promise to provide even better outcomes in some instances. They involve less pain, rapid recoveries, and reduced risks of wound complications, including scar tissue formation, hernias, or other related infections. As a result, the rising awareness among patients of these benefits is leading to frequent hospital visits for GI treatment and, in turn, indicating new directions for the Global Minimally Invasive Gastrointestinal Surgical Systems Market to expand notably in the coming years.
However, the uncertain regulatory framework, significantly high costs of minimally invasive surgeries, lack of skilled professionals, inadequate or limited reimbursement policies for surgical procedures, and long waiting queues for patients across most regions worldwide are the major growth restraints to the Global Minimally Invasive Gastrointestinal Surgical Systems Market during 2022-27.
Based on Product Type:
Of all product types, Endoscopes & Endoscopy Systems hold a larger share in the Global Minimally Invasive Gastrointestinal Surgical Systems Market, and the same trend is expected during 2022-27. The relatively low costs of endoscopic procedures and significant technological advancements in such therapeutics, like capsule endoscopy, to diagnose & treat various GI disorders observed extensively in the elderly population is the prime reason behind the dominance of endoscopes & endoscopy systems in the global market.
However, surgical robotics is a new approach to treating GI diseases and is becoming widely popular worldwide. It owes to its advantages like enhanced accuracy, stability, superior range of motion, power backup, and excellent safety, among many others. Robotics has become a gold standard approach to treating GI disorders as patients have fewer infections, hernias, & less scarring. These systems help overcome challenges associated with endoscopy systems like the limited line of sight and provide surgeons with exceptionally advanced hand skills & visions.
The high precision of robotic systems allows for accurate positioning of implants and minimizes the risk of injuries to surrounding tissues. Fewer hospital readmissions and less bleeding & post-operative pain are major benefits these systems provide to patients. With the growing complexity of procedures to treat different GI ailments, robots are undergoing significant advancements and becoming more & more crucial in minimally invasive surgeries, owing to the massive demand for automation across hospitals to streamline workflows & minimize the labor burden. Hence, these aspects cite lucrative prospects for surgical robotics to attain a considerable share in the Global Minimally Invasive Gastrointestinal Surgical Systems Market over the coming years.
Based on Surgery:
Here, hernia repair surgery holds the largest market share, owing primarily to a massive pool of hernia patients and efficient healthcare facilities, especially in the US. The increasing elderly population and sedentary lifestyles are the most prominent reasons behind the rapid rise in hernia patients globally. In addition, rising healthcare expenditure and quick FDA approvals for new therapeutics are aiding in the discovery & development of new & innovative surgical systems for hernia patients.
Moreover, the widening availability of minimally invasive hernia repair devices, coupled with the growing acceptance of biologic allograft mesh with improved efficiencies that allow for reduced post-surgery pain & faster recovery, are also contributing to the market growth. Furthermore, the extensive adoption of robotic systems in hernia repair surgical procedures and an overall improving healthcare infrastructure worldwide shall continue to boost the Global Minimally Invasive Gastrointestinal Surgical Systems Market in the years ahead.
Geographically, the Global Minimally Invasive Gastrointestinal Surgical Systems Market expands across:
Of all regions, North America is the largest Minimally Invasive Gastrointestinal Surgical Systems Market globally. It is driven by numerous aspects, including but not limited to world-class medical facilities, massive investments in the healthcare sector to bring innovations in different therapeutics, like surgical robots, and the ever-increasing prevalence of chronic diseases in the region.
Lifestyle changes, poor eating habits, limited physical activity, and easy availability & frequent intake of therapeutic drugs are resulting in the growing patient pool for various GI diseases like hernia, IBS, and diarrhea, among others. Besides, the rapidly rising obese & geriatric population and the increasing positive patient outcomes of minimally invasive surgeries for GI diseases are also contributing to the regional market expansion.
Moreover, various government initiatives for providing access to treatment & preventive measures are also creating new directions for the companies participating in the North America Minimally Invasive Gastrointestinal Surgical Systems Market through 2027.
Key Growth Driver
Innovations in Surgical Systems & Increasing Prevalence of GI Disorders Worldwide
The healthcare sector is witnessing massive R&D investments in the innovation & development of more efficient minimally invasive surgeries for various diseases, including GI disorders, the patient pool of which is rapidly rising globally. Governments of different countries are taking various initiatives toward making more & more people aware of the increasing availability of more efficient therapeutics, owing to which there's a rising number of hospital visits for GI treatment. Hence, these aspects are projected to create lucrative prospects for the Global Minimally Invasive Gastrointestinal Surgical Systems Market during 2022-27.
Key Questions Answered in the Market Research Report:
Frequently Asked Questions
A. The Global Minimally Invasive Gastrointestinal Surgical Systems Market is expected to record around 7% CAGR during 2022-27.
A. The growing incidence of gastrointestinal diseases and the widening adoption of minimally invasive surgeries for their treatment owing to the increasing number of efficient & positive patient outcomes are the prime factors likely to drive the Global Minimally Invasive Gastrointestinal Surgical Systems Market during 2022-27. On the other hand, the high cost of minimally invasive surgeries and limited reimbursement policies for surgical procedures in most regions of the world might act as prominent growth restraints for the market in the coming years.
A. Surgical Robotic Systems would be the key growth area for the leading companies in the Global Minimally Invasive Gastrointestinal Surgical Systems Market during 2022-27.
A. North America would continue generating new directions for the Global Minimally Invasive Gastrointestinal Surgical Systems Market to witness significant growth in the years ahead.